Industry experts discussed the big issues facing accountable care organizations (ACO) at the Brookings Institute's event, The State of Accountable Care: Evidence to Date and Next Steps, held Monday in Washington, DC.
Industry experts discussed the big issues facing accountable care organizations (ACO) at the Brookings Institute’s event, The State of Accountable Care: Evidence to Date and Next Steps, held Monday in Washington, DC.
There are many challenges for hospitals that have become ACOs or are considering doing so, including engaging beneficiaries, payment formulas, combining ACO reforms with other payment reforms, and identifying best practices for clinical transformation.
Kelly Taylor, director of care management and quality at Mercy Clinics, explained that it was her organization’s drive to keep pushing forward even during the difficult times that made it become successful. Mercy’s Medicare ACO is participating in the Medicare Shared Savings Program and received a shared savings payment this year.
According to Ms Taylor, the physicians were the most difficult individuals to get on board when transitioning over to an ACO. In comparison, the patients were happy enough to make the change if it meant being more involved.
“Most patients want to be part of what’s going on in their life,” she said. “I think it’s a big reason why we’ve had issues with low medication adherence or low quality outcomes. The patient is really the missing piece.”
Patient engagement is one of the biggest concerns about ACOs, according to Jennifer Sweeney, vice president of the National Partnership for Women and Families. Although her organization has looked at ACOs as a benefit from the beginning, one issue is that they can devolve into just a financial mechanism instead of taking the time to truly transform care, she said.
“What I’m not seeing is collaboration between consumer organizations and ACOs,” Ms Sweeney said. “Consumer groups have expertise when it comes to communicating with patients and families.”
She added that consumer organizations, like her own, are open to working with ACOs to figure out these problems and lend a hand. For hospitals concerned about patients staying in an ACO, Ms Sweeney recommends avoiding marketing, which she called a “misguided approach.” There is no need to treat ACOs like a sales pitch when consumers are getting the kind of patient-centered care they want. Instead, she suggests building awareness through an educational approach.
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Covered Preventive Services at Risk: V-BID Summit Breaks Down the Braidwood v Becerra Case
March 20th 2024For more than a decade, certain high-value preventive care services have been covered at no cost to patients under the Affordable Care Act, but a current legal challenge has the coverage at risk.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Most private health insurers have yet to publish criteria for when they will cover postpartum depression drug, zuranolone; state lawmakers are increasingly opposing health care mergers that they believe do not serve the public interest; Medicaid extensions made in 2021 led to a 40% decline in postpartum lack of insurance.
Read More
President Biden will preview his plan to more than double the size of Medicare’s new drug price negotiation program in the upcoming State of the Union address; Mexicans and Central Americans were most affected by the pandemic in terms of all-cause mortality; two Alabama fertility clinics said they expect to resume in vitro fertilization (IVF) services after a bill was passed to protect doctors.
Read More